This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Treatment of Myoclonus in Dyssynergia Cerebellaris Myoclonica

Ernest R. Somerville, MRCP; C. Warren Olanow, MD

Arch Neurol. 1982;39(8):527-528.

Abstract
• Valproic acid produced marked reduction in myoclonus in a patient with dyssynergia cerebellaris myoclonica (DCM), resulting in substantial functional improvement. These results justify a trial of valproic acid in patients with DCM who are disabled by myoclonus.

Author Affiliations
From the Department of Medicine (Neurology), Duke University Medical Center, Durham, NC.

Footnotes
Accepted for publication Jan 31, 1982.

Reprint requests to Box 2905, Duke University Medical Center, Durham, NC 27710 (Dr Olanow).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Childhood Myoclonus With Botulinum Toxin Type A
Awaad et al.
J Child Neurol 1999;14:781-786.
ABSTRACT  

Baclofen in the Treatment of Polymyoclonus in a Patient With Unverricht-Lundborg Disease
Awaad and Fish
J Child Neurol 1995;10:68-70.